News

The Lancet1d
From innovation to impact in cardiovascular disease
Cardiovascular disease remains the world's leading cause of death and a major source of disability. Global deaths due to ...
Gilead's HIV Pipeline Gains Traction With Upcoming FDA Decision For HIV-1 Drug
Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.
A New Shot Prevents HIV—and Breathes New Life Into a Stagnant Biotech
It trades at 13.3 times forward earnings—below the industry average of 14, as measured by the NYSE Arca Pharmaceutical Index, ...
The Lancet2d
The impact of the PEPFAR funding freeze on HIV deaths and infections: a mathematical modelling study of seven countries in sub-Saharan Africa
aaSouth African Centre for Epidemiological Modelling and Analysis, Centre for Epidemic Response and Innovation, School for Data Science and Computational Thinking, Stellenbosch University, ...